Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sepsis and coagulation.

J L Diehl1, D Borgel

  • 1Paris Descartes University, Faculty of Medicine Paris Descartes, INSERM, AP-HP, Hôpital Européen Georges Pompidou Service de Réanimation Médicale, France. jean-luc.diehl@egp.aphp.fr

Current Opinion in Critical Care
|September 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of cardiac arrest survivors: Protocol of the DESAC (Devenir des survivants d'Arrets Cardiaques) study, a French multicentric prospective cohort.

Resuscitation plus·2023
Same author

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

Evolution of the nutritional status of COVID-19 critically-ill patients: A prospective observational study from ICU admission to three months after ICU discharge.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

A 2-year multicenter, observational, prospective, cohort study on extracorporeal CO<sub>2</sub> removal in a large metropolis area.

Journal of intensive care·2019
Same author

ECCO<sub>2</sub>R patients: look out for coloured urine.

Intensive care medicine·2019
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
Same journal

Multinational collaborations in critical care research: feasible and useful?

Current opinion in critical care·2026
See all related articles

Severe sepsis involves coagulation system dysregulation, particularly the protein C pathway. Identifying patients with impaired protein C activation may improve treatment with activated protein C infusion.

Area of Science:

  • Coagulation and Fibrinolysis
  • Sepsis Pathophysiology
  • Molecular Biology

Background:

  • Dysregulation of coagulation and fibrinolysis is central to severe sepsis.
  • The protein C system is a key focus in sepsis pathophysiology.
  • Recombinant human activated protein C is approved for severe sepsis treatment.

Purpose of the Study:

  • To review recent findings on the protein C system in sepsis.
  • To explore the roles of tissue factor, platelets, and protein S.
  • To link fundamental biological data with clinical findings in sepsis.

Main Methods:

  • Review of recent experimental and clinical studies.
  • Analysis of the thrombomodulin-protein C-endothelial protein C receptor complex.
  • Investigation of cellular effects via protease-activated receptor 1.

Related Experiment Videos

Main Results:

  • Enhanced understanding of the thrombomodulin-protein C-endothelial protein C receptor complex and its cellular effects.
  • Growing evidence for the roles of platelets, von Willebrand factor, tissue factor, and protein S.
  • Potential to identify sepsis patients with impaired protein C activation for targeted therapy.

Conclusions:

  • Progress in understanding the protein C pathway in sepsis, both experimentally and clinically.
  • Investigation of other promising coagulant pathways for future sepsis treatments.
  • Hope for significant future clinical implications in sepsis management.